drug

tepotinib

1 story · latest Nov 9, 2026

Follow tepotinib. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: FDA approved Feb 2021 · NDA214096
Brand: Tepmetko

Relationships

Developed by Merck KGaA

Also known as

tepotinib hydrochloride

Timeline

FDA grants traditional approval to tepotinib for MET exon 14 NSCLC

Nov 9Regulatory decisionMerck KGaA tepotinib

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.